一个关于LRRK2,Rab GTPases和帕金森病之间的相互作用的更新
Tadayuki Komori1, Tomoki Kuwahara1
1Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
Biomolecules
|November 25, 2023
概括
本综述探讨了内解体缺陷与帕金森病 (PD) 之间的联系. 它强调了Rab GTPases的作用,以及它们与富含白的重复激酶2 (LRRK2) 在PD病变发生过程中的相互作用.
科学领域:
- 神经生物学 神经生物学 神经生物学
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 神经退行性疾病研究取得了进展,发现了新的病理生物学机制.
- 帕金森病 (PD) 研究越来越多地指向内溶酶体系统缺陷.
- 内分泌体系统调节囊泡流通,这对细胞平衡至关重要.
研究的目的:
- 审查最近关于白丰富的重复激酶2 (LRRK2) 和Rab GTPases在PD中的发现.
- 为了阐明LRRK2和Rab GTPases之间的相互作用.
- 了解这些相互作用对帕金森病发病的贡献.
主要方法:
- 关于LRRK2,Rab GTPases和PD的最近研究的文献综述.
- 分析LRRK2与各种Rab GTPases之间的功能相互作用.
- 综合当前有关PD内酶体通路参与的知识.
主要成果:
- 最近的研究表明,在帕金森病中存在内溶性体缺陷.
- 拉布GTPases是内分泌体系统的关键调节者.
- LRRK2与特定的Rab GTPases之间的相互作用是PD研究的一个重要领域.
结论:
- 了解LRRK2-Rab GTPase相互作用对于PD病理生物学至关重要.
- 由LRRK2和Rab GTPases调节的内解体系统的缺陷是PD的核心.
- 对这些相互作用的进一步研究可能会揭示帕金森病的新型治疗点.
相关概念视频
Rab Proteins
3.9K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
3.9K
Rab Cascades
2.7K
Rab GTPases act in a regulated cascade during membrane fusion, helping the lipid bilayers mix. The Rab family of proteins are active when bound to GTP, and inactive when bound to GDP. Hence, they act as guanine nucleotide-dependent molecular switches. Rab-GTP recognizes and binds to long or short-range tethering proteins to capture the target vesicle. These tethers coordinate with SNAREs on the vesicle and the target membrane to assemble the trans SNARE complex that locks the mixing bilayers.
2.7K
Parkinson's Disease: Overview
557
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
557
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Small GTPases - Ras and Rho
4.0K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.0K
Parkinson's Disease: Treatment
276
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
276


